Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

NCT02103335 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma in Relapse
Refractory Multiple Myeloma
Multiple Myeloma

Interventions

DRUG: pomalidomide
DRUG: marizomib
DRUG: low-dose dexamethasone

Sponsor

Celgene

Collaborators

[object Object]